Introduction: Jaundice is an important problem in the neonatal period especially in the first week of life. Our objective of the study is to find out the immediate outcome of hyperbilirubinemic babies admitted in Kanti Children Hospital. Methodology: This is a retrospective study and carried out in tertiary care paediatric hospital. Results: Altogether 73 babies were enrolled in the study. Male babies outnumbered the female (72.6% vs. 27.4%).Only 2.4% babies were near-term. LBW babies constitute 19.2% of the study population.86.3% of babies also have clinical sepses as defined by WHO criteria. Almost half of the babies have mild hyperbilirubinemia (15-19.9 mg/dl). Most of the babies (94.5%) improved and the mortality was 5.5%. Conclusion: Healthy term babies with a serum bilirubin <17mg/dl should not be admitted for routinely as they do not need phototherapy. Phototherapy is effective in most of the time, but exchange transfusion should also be carried out when phototherapy fails. Causes of hyperbilirubinemia should be searched extensively especially to rule out haemolysis.
Introduction

J
aundice is an important problem in the newborn period, especially in the fi rst week of life. It is a cause of concern for the physician and a source of anxiety for the parents. Jaundice in the newborn is a unique problem because most of the time it is unconjugated hyperbilirubinemia which when elevated at pathological range is potentially toxic to infants developing brain and may lead to kernicterus. Most cases of jaundice in the newborn are benign, but because of the potential toxicity of bilirubin, newborn infant must be monitored to identify those who might develop severe hyperbilirubinemia and in rare cases acute bilirubin encephalopathy or kernicterus 1 . Nearly 60% of the terms neonates become visibly jaundiced in the fi rst week of life 2 . Even higher percentages of preterm infants are at risk of developing jaundice. National Neonatal Perinatal Database Network of India reported that 5.7% neonates required phototherapy for jaundice 3 . Of the infants defi ned as hyperbilirubinemia, the maximum level of serum total bilirubin (STB) exceeded 20 mg/dl (342μmol/L) in 2% representing 0.25% of all the births 2 . Approximately 2-4% of exclusively breastfed term babies have jaundice in excess of 10 mg/dl in the fi rst week of life 4 .
Hyperbilirubinemia in newborn is defi ned as need for phototherapy as stated by American Academy of Pediatrics (AAP) guidelines 5 . Chemical hyperbilirubinemia, defi ned as a total serum bilirubin level of 2.0 mg/dl (34μmol/L) or more is virtually universal in newborn during the fi rst week of life 3 . Traditionally a distinction has been made between benign physiologic jaundice and hyperbilirubinemia which is either pathologic in origin or severe enough to be considered deserving of further evaluation and intervention. The latter entity has been called "non physiologic" or pathologic jaundice if the concentration of bilirubin exceeds 5 mg/dl (86 μmol/L) on the fi rst day of life in a term neonate, 10mg/ dl (171μmol/L) in second day, or 12-13mg/dl (205-222μmol/L) thereafter, based on data from the National Collaborative Perinatal Project total serum bilirubin elevation exceeding 17Mg/dl (291μmol/L) should be presumed pathologic and warrants investigation for a cause and possible therapeutic intervention such as pototherapy 6, 7 . Low concentration of bilirubin may have some antioxidant benefi ts, suggesting it should not be completely eliminated 8 . The risk of developing Kernicterus is generally confi ned in neonates whose total serum bilirubin concentration rises to values greater than 20-24 mg/dl (340-408μmol/L) 9 . Because most of the dangerous or extreme hyperbilirubinemia are related to haemolysis, identifi cation of overproduction of bilirubin is useful in the early identifi cation of bilirubin toxicity 1 . Kanti Children Hospital is the only tertiary care Hospital in the country with neonatal intensive care facilities where most of the sick neonates are referred for appropriate care. Neo-natal Jaundice (NNJ) is one of the common reasons for admission and treatment. There has been no recent study on NNJ at this hospital so it was considered to be worthful doing this study. Objectives of this study were to fi nd out the immediate outcomes of hyperbilirubinemic babies and also to fi nd out the associated co morbid condition with neonatal Jaundice.
Methodology
This is a retrospective observational study. It has been done in a tertiary care paediatric hospital (Kanti Children Hospital). Subjects and methodology: All terms and near terms (35-36weeks) neonates admitted to Kanti Children Hospital with the diagnosis of neonatal jaundice (NNJ) and total serum bilirubin level >15 mg/dl were assessed for the maximum level of bilirubin. Those babies who were admitted to Kanti Children Hospital either in NIMCU (Neonatal Intermediate Care Unit) or in NICU from the 1st of March to the 1st of June 2009 were included in the study. Measurements of s.bilirubin level were done by two biochemical methods; fi rst the High Performance Liquid Chromatography (HPLC) method, which remains the gold standard method for bilirubin measurement and measures total as well as direct fraction of bilirubin based on the Van den Bergh reaction. Secondly the twin beam microbilimeter based on spectro photometry which estimates unconjugated bilirubin only.
All the neonates having hyperbilirubinaemia were treated with phototherapy; those babies who also have sepsis including meningitis also received antibiotics. Immediate outcomes were studied in the form of complete recovery, recovered with neurological impairments and death. Data were analysed by using SPSS software.
Results
All together 361 neonates had been admitted in Kanti Children Hospital during the study period. Among them 73 babies fulfi lled the study criteria for enrolment which constituted 20% of neonatal morbidity. Male babies outnumbered female babies i.e. 53 (72.6%) were male babies. 40 (54.8%) babies were born to primi Para mother. Only 6(8.2%) babies were near-term. LBW babies constituted 14 (19.2%). Only 17 (23.3%) babies were delivered at home.
Clinical sepsis as defi ned by WHO criteria was found in 86.3% of babies and among them 9.6% cases were culture proven. Almost half of the babies had only moderate hyperbilirubinaemia (15-19.9mg/dl). Nearly 1/3rd (32.9%) babies were ABO incompatible and 4.1% babies were Rh incompatible. Most of the babies' i.e. 69 (94.5%) improved completely and death was observed in only 4 (5.5%) babies.
As sepsis is the commonest cause of admission in neonatal period in our hospital, every baby is screened for sepsis; a lumbar puncture is done in symptomatic sepsis. Fig. 1 shows the percentage of babies with clinical sepsis, Septic screen positive sepsis, and culture proven sepsis, meningitis and birth asphyxia in hyperbilirubinemic babies. Fig. 2 shows maximum level of s.bilirubin during hospital stay, more than two third babies have mild hyperbilirubinemia i.e. their bilirubin falls in between 15-19.9 mg%,only 3% of babies have maximum rise of serum bilirubin i.e. >30mg%. 
Table1: Showing Demographic Variables of the Study Population.
Variables
Discussion
Hyperbilirubinemia is one of the most common causes of hospital admission in nurseries. Although jaundice is a benign condition; infants must be monitored to identify those who might develop acute bilirubin encephalopathy or kernicterus. Although kernicterus should almost always be preventable, cases continue to occur in infants of 35 or more weeks' gestation.
The following are the key elements of the recommendation by AAP guideline: Every clinician should: 1) Promote and support successful breast feeding.
2) Perform a systematic assessment before discharge for the risk of severe hyperbilirubinemia.
3) Provide early and focussed follow-up based on the risk assessment. 4) When indicated, treat newborn with phototherapy or exchange transfusion to prevent the development of severe hyperbilirubinemia and possible bilirubin encephalopathy 4 .
Infants with 35-37 weeks of gestation were usually treated in well infant nurseries as if they were term infants and managed no differently from those of ≥38weeks' gestation with respect to diagnosis, treatment and follow-up of hyperbilirubinemia 10 . However in another study of infants born at 37weeks' gestation were much more likely (4 times) to develop a serum bilirubin level of ≥ 13 mg/dl than those born to 40 weeks of gestation 11 . AAP guidelines (subcommittee on hyperbilirubinemia) recommend that infants at medium risk (≥38 weeks + risk factors or 35-37 6/7 weeks and well) and infant at higher risk (35-37 6/7weeks +risk factors) should be treated at lower bilirubin level as compared to infants at lower risk (≥38 weeks and well) in order to prevent kernicterus 4 .
There is a strong association between breastfeeding and jaundice in the healthy newborn infants. We have observed that 93.6% hyperbilirubinaemic babies were on exclusive breastfeeding. This might be due to universal breastfeeding practices in Nepal. Similar fi nding was observed by Jeffeyet al. He found that of infants for whom no causes for hyperbilirubinaemia was found, 82.7% were breastfed compared to 46.9% in control group (p<.0001) 12 .
We observed that maximum number (67.1%) of infants' peak serum bilirubin fell in the range of 15-19.9 mg/dl, and the mean serum bilirubin was 400μmol/L. Similar result was observed by Sgro et al who found that mean peak serum bilirubin was 471μmol/L 13 . In our study ABO incompability was found in 32.9% of cases while in another study it was 51.6% 10 . In our study culture proved sepsis was found in 9.6% of hyperbilirubinemic babies, where as in the study by Awasthi et al culture positive was seen in only 1.1% 14 . However Narang et al mention that sepsis contributed to only 4.49% cases of hyperbilirubinemia 15 . In our study hyperbilirubinemia was more common in male babies as compared to female babies (72.6% vs. 27.4%), similar fi nding were observed by Mantani et al (62% vs. 38%) and Sharma et al (1.3:1) 16,17 . Interestingly we observed that peak serum bilirubin or total serum bilirubin did not have any correlation with the fi nal outcome which was also observed by Mantani et al 16 .
Conclusion
To conclude hyperbilirubinemia is one of the most common causes of hospital admission in our nursery and it is associated with various other clinical morbidities. Healthy term babies with a serum bilirubin <17mg/dl should not be admitted for routinely as they do not need phototherapy. Phototherapy is effective in most of the time, but exchange transfusion should also be carried out when phototherapy fails. Causes of hyperbilirubinemia should be searched extensively especially to rule out haemolysis (ABO and RH typing should be routinely done along with Direct Coombs Test, peripheral smear, retics count and G6PD screening). Detailed neurological examination during admission and at discharge should be recorded.
